Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Babies in a rural area of India are less likely to suffer from acute malnutrition where their families are taking part in a job-guarantee programme to provide work with a guaranteed wage, an Oxford University study has found. The Indian government programme appears to have no effect on long-term malnutrition.

While wages earned through the scheme helped families avoid starvation when seasonal agricultural jobs were in short supply, many mothers complained wages were paid late or not in full. This means that the intended benefits of the programme were not delivered in full, the researchers say.

The Mahatma Gandhi National Rural Employment Guarantee Act (MGNREGA) is a job-guarantee scheme in rural India which provides adults willing to do unskilled manual work with at least 100 days of work in every financial year, paid at the statutory minimum wage. MGNREGA is intended to target deprivation and food insecurity in rural households, and because of this, it has been suggested the policy may indirectly improve the health of babies and young children in these households.

Since child malnutrition is a major public health problem in India, researchers at the University of Oxford set out to investigate whether MGNREGA could improve the nutritional status of children below the age of 12 months. This is thought to be the first study to analyse the effect of the MGNREGA programme on infant nutrition. The team measured the weight and length of infants in 528 households spread across the Dungarpur district of Rajasthan, where MGNREGA has been implemented since September 2006. 53% of these households had received employment through MGNREGA during the study period. The researchers also interviewed the mothers of these children and conducted 11 focus group discussions with 62 of the mothers. 

Dr Manisha Nair of the Nuffield Department of Population Health at Oxford University led and carried out the study as part of her DPhil research as a Weidenfeld scholar. She says: ‘We found that children in households employed through the MGNREGA programme were less likely to suffer from recent malnutrition compared with children in households that did not participate in the scheme. However, we did not find any effect of the programme on long term malnutrition.’

The researchers used statistical modelling to understand the likely cause of this beneficial effect on infant nutrition. They found that the effect was not because of improvements in household food security or infant feeding, which they would have expected. Instead, it came through improved birth weights of the infants.

‘It is possible that the programme contributes to better nutrition in pregnant women which leads to improved birth weight,’ suggests Dr Nair, who is originally from Assam and did her medical training at Assam Medical College in Dibrugarh. ‘However further investigation is needed to examine this.’

As well as complaints about problems with receiving wages earned through MGNREGA, the focus group discussions showed that a number of mothers didn’t have a full understanding of appropriate feeding and weaning of infants. The researchers say this could act as a barrier to translating the full economic benefits of the guaranteed wage.

‘It is important to identify and address these factors and target the persistent problem of child malnutrition prevalent in India through a convergence of development, health and nutrition policies and programmes,’ says Dr Nair.

The positive effect of the MGNREGA programme on childhood nutrition was observed only in the poorest households, the researchers report. At present, households can participate in MGNREGA regardless of their socioeconomic status, though the programme’s design tends to ensure that only those that need it apply. However, among the households included in this study, 44% of the poorer households did not receive employment through MGNREGA while around 50% of the relatively better off households did. The team suggests that better targeting of the scheme towards the more disadvantaged households could increase the effectiveness of MGNREGA, making better use of limited resources.

‘This study shows that the MGNREGA programme has the potential to reduce recent malnutrition in children. However, the economic benefits of the job guarantee scheme appear to be short term, and insufficient to have an effect on long term malnutrition,’ concludes Dr Nair. ‘Ensuring timely and adequate payment could improve food security and increase the protective effect of the programme.’

She says similar studies are required to measure the effect of MGNREGA on child nutrition in different social, economic and geographical settings in India.

The researchers report their findings in the journal PLOS ONE

Source: Oxford University press release

Link: 
Nuffield Department of Population Health

Similar stories

QCovid highly commended for ‘best use of technology in Patient Safety’ at the 2021 HSJ Patient Safety Awards

Professor Julia Hippisley-Cox and her team in Nuffield Department of Primary Care Health Sciences have been Highly Commended in the ‘Best use of technology in Patient Safety’ category for the QCovid risk calculator at this year’s Health Service Journal Patient Safety Awards.

New guidelines to improve reporting standards of studies that investigate causal mechanisms

Researchers in the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) have developed a new set of guidelines for reporting mediation analyses in health research.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.

Com-COV vaccine mix-and-match study expands to 12-to-16-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a new study of COVID-19 vaccination schedules in young people aged 12 to 16.